Allena Pharmaceuticals, Inc. Dividends (Preferred)

Dividends (Preferred) of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Dividends (Preferred) growth rates and interactive chart. Preferred dividends are the dividends that are accrued paid on a company's preferred stock. Any time a company pays dividends, preferred shareholders have priority over common shareholders, which means dividends must always be paid to preferred shareholders before they are paid to common shareholders


Highlights and Quick Summary

  • Dividends (Preferred) for the quarter ending December 31, 2021 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Dividends (Preferred) decreased by NaN%
  • Annual Dividends (Preferred) for 2021 was $0 (a NaN% decrease from previous year)
  • Annual Dividends (Preferred) for 2019 was $0 (a NaN% decrease from previous year)
Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Dividends (Preferred) of Allena Pharmaceuticals, Inc.

Most recent Dividends (Preferred)of ALNA including historical data for past 10 years.

Interactive Chart of Dividends (Preferred) of Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Dividends (Preferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0
2018 $0.0
2017 $0.0

Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.